Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome

Nicholas T Funderburg1, David A Zidar, Carey Shive

  • 1Department of Medicine, Division of Infectious Diseases, Case Western Reserve University/University Hospitals of Cleveland, Cleveland, OH 44106, USA. NTF1@case.edu

Blood
|October 16, 2012
PubMed

Insights

HIV-1 infection alters monocyte subsets, increasing cardiovascular risk. Specific monocyte profiles in HIV-1 patients mirror those seen in acute coronary syndrome, suggesting shared inflammatory drivers.

Area of Science:

  • Immunology
  • Cardiovascular Medicine
  • Virology

Background:

  • The mechanisms linking human immunodeficiency virus type 1 (HIV-1) infection to increased cardiovascular risk are not fully understood.
  • Monocyte subpopulations play a crucial role in immune responses and inflammation, potentially contributing to atherosclerosis.

Purpose of the Study:

  • To investigate and compare the activation phenotypes of monocyte subpopulations in individuals with HIV-1 infection and those with acute coronary syndrome (ACS).
  • To identify common cellular profiles that may explain the elevated cardiovascular risk in HIV-1 infection.

Main Methods:

  • Flow cytometry was employed to analyze monocyte subpopulations (nonclassic and intermediate) and their activation markers (tissue factor, CD62P).
  • Whole blood samples from HIV-1 infected individuals and ACS patients were compared to healthy controls.
  • In vitro experiments exposed control blood to lipopolysaccharide (LPS) and HIV-1 to assess monocyte activation.

Main Results:

  • HIV-1 infection is associated with a proportional increase in nonclassic (CD14(+)CD16(++)) and intermediate (CD14(++)CD16(+)) monocytes.
  • These activated monocytes express high levels of tissue factor and CD62P, correlating with HIV-1 viral load, T-cell activation, and IL-6 levels.
  • In vitro, HIV-1 selectively activated nonclassic monocytes, while LPS activated all subsets; the monocyte activation profile in uncontrolled HIV-1 disease resembles that of ACS.

Conclusions:

  • Immune activation and inflammation in HIV-1 disease significantly alter monocyte subpopulations and their activation phenotypes.
  • These alterations contribute to a pro-atherothrombotic state, thereby increasing cardiovascular risk in individuals with HIV-1 infection.
  • The findings highlight potential therapeutic targets for mitigating cardiovascular complications in HIV-1 patients.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...